Genotypic and haplotypic associations of the DBH gene with plasma dopamine β-hydroxylase activity in African Americans

European Journal of Human Genetics

Volumn 15, Issue 8, 2007, Pages 878-883

  Tang, Yi lang ^a   Epstein, Michael P ^b   Anderson, George M ^c   Zabetian, Cyrus P ^d   Cubells, Joseph F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADULT; AFRICAN AMERICAN; ANALYSIS OF VARIANCE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHENOTYPE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; VALIDATION PROCESS;

ADULT; AFRICAN AMERICANS; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34547150578     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201838     Document Type: Article

References (27)

1. Weinshilboum RM: Human biochemical genetics of plasma dopamine-beta-hydroxylase and erythrocyte catechol-o methyltransferase. Hum Genet Suppl 1978; 101-112.
2. O'Connor DT, Cervenka JH, Stone RA et al: Dopamine betahydroxylase immunoreactivity in human cerebrospinal fluid: Properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin Sci (London) 1994; 86: 149-158.
3. O'Connor DT, Levine GL, Frigon RP: Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: Analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. J Hypertens 1983; 1: 227-233.
4. Dunnette J, Weinshilboum R: Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. Am J Hum Genet 1976; 28: 155-166.
5. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G: Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. J Psychiatr Res 1986; 20: 19-29.
6. Ebstein RP, Park DH, Freedman LS, Levitz SM, Ouchi T, Goldstein M: A radioimmunoassay of human circulatory dopamine-beta-hydroxylase. Life Sci 1973; 13: 769-784.
7. Cubells JF, Kranzler HR, McCance-Katz E et al: A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 2000; 5: 56-63.
8. Cubells JF, Price LH, Meyers BS et al: Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 2002; 51: 358-364.
9. Cubells JF, van Kammen DP, Kelley ME et al: Dopamine beta-hydroxylase: Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 1998; 102: 533-540.
10. Wei J, Ramchand CN, Hemmings GP: Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 1997; 99: 52-55.
11. Zabetian CP, Anderson GM, Buxbaum SG et al: A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001; 68: 515-522.
12. Zabetian CP, Buxbaum SG, Elston RC et al: The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 2003; 72: 1389-1400.
13. Tang Y, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF: Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C - > T) with plasma dopamine beta-hydroxylase activity. Am J Med Genet B Neuropsychiatr Genet 2005; 139: 88-90.
14. Tang Y, Buxbaum SG, Waldman I et al: A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/ hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 2006; 60: 1034-1038.
15. Kohnke MD, Zabetian CP, Anderson GM et al: A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 2002; 52: 1151-1158.
16. Cubells JF, Zabetian CP: Human genetics of plasma dopamine beta-hydroxylase activity: Applications to research in psychiatry and neurology. Psychopharmacology (Berl) 2004; 174: 463-476.
17. D'Amato T, Leboyer M, Malafosse A et al: Two TaqI dimorphic sites at the human beta-hydroxylase locus. Nucleic Acids Res 1989; 17 5871.
18. Wu S, Muhleman D, Comings D: PCR amplification of the Taq I B1/B2 polymorphism at intron 5 of the dopamine beta-hydroxylase gene. Psychiatr Genet 1997; 7: 39-40.
19. Daly G, Hawi Z, Fitzgerald M, Gill M: Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192-196.
20. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH: Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 2002; 114: 154-158.
21. Smith KM, Daly M, Fischer M et al: Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 2003; 119B: 77-85.
22. Cubells JF, Kobayashi K, Nagatsu T et al: Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 1997; 74: 374-379.
23. BarreAt JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
24. Wilson AF, Elston RC, Siervogel RM, Tran LD: Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet 1988; 42: 160-166.
25. Lake SL, Lyon H, Tantisira K et al: Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 56-65.
26. Purcell S, Sham P: WHAP (haplotype-based association analysis package). Cambridge, MA.
27. The International HapMap Consortium: A haplotype map of the human genome. Nature 2005; 437: 1299-1320.